Budget negotiation for industry-sponsored clinical trials

Anesthesia and Analgesia

Volumn 99, Issue 1, 2004, Pages 173-176

  Beal, Kristy ^a   Dean, Juliette ^a   Chen, James ^a   Dragaon, Elena ^a   Saulino, Ann ^a   Collard, Charles D ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; BUDGET; CLINICAL RESEARCH; CLINICAL TRIAL; COST; ORGANIZATION; PLANNING; PRIORITY JOURNAL; REVIEW;

EID: 3042565623     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000122633.97424.76     Document Type: Review

References (8)

1. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539-44.
2. Staropoli JF. MSJAMA: funding and practice of biomedical research. JAMA 2003;290:112.
3. Nathan DG. Clinical research: perceptions, reality, and proposed solutions: National Institutes of Health Director's Panel on Clinical Research. JAMA 1998;280:1427-31.
4. Miller RD. The place of research and the role of academic anaesthetists in anaesthetic departments. Best Pract Res Clin Anaesthesiol 2002;16:353-70.
5. Cavan BN. Improving clinical trials cost management in biotech companies. Biotechnology 1995;13:226-8.
6. Backhouse ME. An investment appraisal approach to clinical trial design. Health Econ 1998;7:605-19.
7. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996;5:513-24.
8. Scheifele DW. Clinical trials and tribulations: a personal view of interacting with pharmaceutical manufacturers. Clin Invest Med 1997;20:188-92.